Despite differences in the results, the studies show that immunological responses are compromised in liver tumors in the event of elevated HHLA2 expression, meaning that HHLA2 is likely to induce immune escape in ICC and HCC. Here, HHLA2 is linked to intrahepatic cholangiocarcinoma.